Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rault

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|March 14, 2001
Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxietyP Delagrange, R Misslin, T W Seale, et al.
Journal of the American Academy of Dermatology|April 1, 1997
Spiny keratodermaV Salmon-Ehr, P Armingaud, M P Cambie-Vanderschelden, et al.
The Journal of Organic Chemistry|October 29, 2000
Reactivity of 3-iodoimidazo[1,2-a]pyridines using a Suzuki-type cross-coupling reactionC Enguehard, J L Renou, V Collot, et al.
The Journal of Pharmacy and Pharmacology|February 24, 2001
Synthesis of new 2-(aminomethyl)-4-phenylpyrrolo[1,2-a]-quinoxalines and their preliminary in-vivo central dopamine antagonist activity evaluation in miceJ Guillon, M Boulouard, V Lisowski, et al.
Chemical & Pharmaceutical Bulletin|May 1, 1987
[Structural study of an analog of ellipticine designed as antineoplastic, 1,4-dihydro-4-oxo-2,5,11-trimethyl-6H-pyrido[3,2-b]carbazole, with X-ray diffraction]B Viossat, N H Dung, J C Lancelot, et al.
Chemical & Pharmaceutical Bulletin|May 14, 1998
Synthesis and evaluation of the CNS activity of new 4-alkoxyphenylimidazolidin-2-onesJ Guillon, V Lelong, O Renault, et al.
International Journal of Pharmaceutics|May 26, 2006
Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agentA Malzert-Fréon, S Vrignaud, P Saulnier, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 11, 2010
Influence of the introduction of a solubility enhancer on the formulation of lipidic nanoparticles with improved drug loading ratesA Malzert-Fréon, G Saint-Lorant, D Hennequin, et al.
Chemical & Pharmaceutical Bulletin|August 1, 1994
Synthesis and cytotoxic activity against L1210 leukemia of new aminocyclopenta[c]thiophenonesA Alsaidi, S al Shargapi, P Dallemagne, et al.
Journal of Chemical Information and Computer Sciences|June 21, 2001
Association of two 3D QSAR analyses. application to the study of partial agonist serotonin-3 ligandsR Bureau, C Daveu, I Baglin, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|March 14, 2001
Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxietyP Delagrange, R Misslin, T W Seale, et al.
Journal of the American Academy of Dermatology|April 1, 1997
Spiny keratodermaV Salmon-Ehr, P Armingaud, M P Cambie-Vanderschelden, et al.
The Journal of Organic Chemistry|October 29, 2000
Reactivity of 3-iodoimidazo[1,2-a]pyridines using a Suzuki-type cross-coupling reactionC Enguehard, J L Renou, V Collot, et al.
The Journal of Pharmacy and Pharmacology|February 24, 2001
Synthesis of new 2-(aminomethyl)-4-phenylpyrrolo[1,2-a]-quinoxalines and their preliminary in-vivo central dopamine antagonist activity evaluation in miceJ Guillon, M Boulouard, V Lisowski, et al.
Chemical & Pharmaceutical Bulletin|May 1, 1987
[Structural study of an analog of ellipticine designed as antineoplastic, 1,4-dihydro-4-oxo-2,5,11-trimethyl-6H-pyrido[3,2-b]carbazole, with X-ray diffraction]B Viossat, N H Dung, J C Lancelot, et al.
Chemical & Pharmaceutical Bulletin|May 14, 1998
Synthesis and evaluation of the CNS activity of new 4-alkoxyphenylimidazolidin-2-onesJ Guillon, V Lelong, O Renault, et al.
International Journal of Pharmaceutics|May 26, 2006
Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agentA Malzert-Fréon, S Vrignaud, P Saulnier, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 11, 2010
Influence of the introduction of a solubility enhancer on the formulation of lipidic nanoparticles with improved drug loading ratesA Malzert-Fréon, G Saint-Lorant, D Hennequin, et al.
Chemical & Pharmaceutical Bulletin|August 1, 1994
Synthesis and cytotoxic activity against L1210 leukemia of new aminocyclopenta[c]thiophenonesA Alsaidi, S al Shargapi, P Dallemagne, et al.
Journal of Chemical Information and Computer Sciences|June 21, 2001
Association of two 3D QSAR analyses. application to the study of partial agonist serotonin-3 ligandsR Bureau, C Daveu, I Baglin, et al.
Pageof 6